Latest News

  • Alkermes Advances ALKS 4230 into Monotherapy Expansion Phase of ARTISTRY-1 in Patients With Renal Cell Carcinoma or Melanoma Read More
  • Alkermes to Present New Data From Mental Health Portfolio at the American Society of Clinical Psychopharmacology 2019 Annual Meeting Read More
  • Alkermes to Present at the UBS Global Healthcare Conference Read More

Investors

Working at Alkermes